The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms
Background: Chronic kidney disease (CKD), driven by progressive renal fibrosis, lacks effective therapeutic targets. This study investigates thrombospondin-4 (THBS4) as a novel mediator of CKD-related fibrosis and explores its mechanistic basis....
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-07-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBL/30/7/10.31083/FBL26076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849236519250821120 |
|---|---|
| author | Xu Yan Kun Zhao Ye Yao Lihui Wang Wei Shan Yan Zhang |
| author_facet | Xu Yan Kun Zhao Ye Yao Lihui Wang Wei Shan Yan Zhang |
| author_sort | Xu Yan |
| collection | DOAJ |
| description | Background: Chronic kidney disease (CKD), driven by progressive renal fibrosis, lacks effective therapeutic targets. This study investigates thrombospondin-4 (THBS4) as a novel mediator of CKD-related fibrosis and explores its mechanistic basis. Methods: This study collected 100 patients diagnosed with chronic kidney disease and 30 healthy individuals. Enzyme-linked immunosorbent assay (ELISA) analysis was conducted to assess the expression of THBS4 in CKD patients. Mouse unilateral ureteral obstruction (UUO) renal fibrosis model and Human Kidney-2 (HK2) cell fibrosis model were constructed to analyze the expression changes of THBS4 in renal fibrosis. To examine the effects of inhibiting THBS4 expression on the process of renal fibrosis, these two models were analyzed using Sirius red staining, Masson staining, immunohistochemistry, real-time quantitative PCR (qPCR) and western blot methods. Results: The expression of THBS4 in the serum of CKD patients was found to be significantly higher (p < 0.05), and its concentration showed a negative correlation with the eGFR levels (r = –0.77, p < 0.05) and an increase corresponding to the progression of CKD stages (p < 0.05). THBS4 expression was dramatically increased in UUO-treated mouse kidneys as well as in TGF-β1-stimulated HK2 cells (p < 0.05). In vitro, the expression of renal fibrosis-associated proteins was also significantly reduced after interfering with THBS4 expression (p < 0.05). UUO-induced renal fibrosis and related protein expression were suppressed in THBS4 knockdown mice when compared to control mice (p < 0.05). The levels of p-AKT and p-PI3K exhibited a significant rise in conjunction with the onset of renal fibrosis (p < 0.05). The expression of p-AKT as well as p-PI3K showed a significant reduction upon inhibition of THBS4 expression (p < 0.05). Insulin-like growth factor 1 (IGF-1) treatment reversed these effects. Conclusion: THBS4 was significantly overexpressed in CKD patients. By suppressing the expression of proteins associated with renal fibrosis and inhibiting the activation of the PI3K/AKT pathway, THBS4 has the potential to mitigate renal fibrosis. |
| format | Article |
| id | doaj-art-6887b012900c4cb8bc219f5cb07df63e |
| institution | Kabale University |
| issn | 2768-6701 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Frontiers in Bioscience-Landmark |
| spelling | doaj-art-6887b012900c4cb8bc219f5cb07df63e2025-08-20T04:02:13ZengIMR PressFrontiers in Bioscience-Landmark2768-67012025-07-013072607610.31083/FBL26076S2768-6701(24)01583-1The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular MechanismsXu Yan0Kun Zhao1Ye Yao2Lihui Wang3Wei Shan4Yan Zhang5Department of Nephrology, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, ChinaCollege of Basic Medical Sciences, Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, ChinaDepartment of Nephrology, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, ChinaDepartment of Nephrology, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, ChinaDepartment of Laboratory Medicine, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, ChinaDepartment of Nephrology, The Second Affiliated Hospital of Qiqihar Medical University, 161006 Qiqihar, Heilongjiang, ChinaBackground: Chronic kidney disease (CKD), driven by progressive renal fibrosis, lacks effective therapeutic targets. This study investigates thrombospondin-4 (THBS4) as a novel mediator of CKD-related fibrosis and explores its mechanistic basis. Methods: This study collected 100 patients diagnosed with chronic kidney disease and 30 healthy individuals. Enzyme-linked immunosorbent assay (ELISA) analysis was conducted to assess the expression of THBS4 in CKD patients. Mouse unilateral ureteral obstruction (UUO) renal fibrosis model and Human Kidney-2 (HK2) cell fibrosis model were constructed to analyze the expression changes of THBS4 in renal fibrosis. To examine the effects of inhibiting THBS4 expression on the process of renal fibrosis, these two models were analyzed using Sirius red staining, Masson staining, immunohistochemistry, real-time quantitative PCR (qPCR) and western blot methods. Results: The expression of THBS4 in the serum of CKD patients was found to be significantly higher (p < 0.05), and its concentration showed a negative correlation with the eGFR levels (r = –0.77, p < 0.05) and an increase corresponding to the progression of CKD stages (p < 0.05). THBS4 expression was dramatically increased in UUO-treated mouse kidneys as well as in TGF-β1-stimulated HK2 cells (p < 0.05). In vitro, the expression of renal fibrosis-associated proteins was also significantly reduced after interfering with THBS4 expression (p < 0.05). UUO-induced renal fibrosis and related protein expression were suppressed in THBS4 knockdown mice when compared to control mice (p < 0.05). The levels of p-AKT and p-PI3K exhibited a significant rise in conjunction with the onset of renal fibrosis (p < 0.05). The expression of p-AKT as well as p-PI3K showed a significant reduction upon inhibition of THBS4 expression (p < 0.05). Insulin-like growth factor 1 (IGF-1) treatment reversed these effects. Conclusion: THBS4 was significantly overexpressed in CKD patients. By suppressing the expression of proteins associated with renal fibrosis and inhibiting the activation of the PI3K/AKT pathway, THBS4 has the potential to mitigate renal fibrosis.https://www.imrpress.com/journal/FBL/30/7/10.31083/FBL26076chronic kidney diseasethrombospondin-4renal fibrosisfibrosis-associated proteinpi3k/akt pathway |
| spellingShingle | Xu Yan Kun Zhao Ye Yao Lihui Wang Wei Shan Yan Zhang The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms Frontiers in Bioscience-Landmark chronic kidney disease thrombospondin-4 renal fibrosis fibrosis-associated protein pi3k/akt pathway |
| title | The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms |
| title_full | The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms |
| title_fullStr | The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms |
| title_full_unstemmed | The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms |
| title_short | The Role of THBS4 in Chronic Kidney Disease Fibrosis: From Clinical Observations to Molecular Mechanisms |
| title_sort | role of thbs4 in chronic kidney disease fibrosis from clinical observations to molecular mechanisms |
| topic | chronic kidney disease thrombospondin-4 renal fibrosis fibrosis-associated protein pi3k/akt pathway |
| url | https://www.imrpress.com/journal/FBL/30/7/10.31083/FBL26076 |
| work_keys_str_mv | AT xuyan theroleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT kunzhao theroleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT yeyao theroleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT lihuiwang theroleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT weishan theroleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT yanzhang theroleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT xuyan roleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT kunzhao roleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT yeyao roleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT lihuiwang roleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT weishan roleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms AT yanzhang roleofthbs4inchronickidneydiseasefibrosisfromclinicalobservationstomolecularmechanisms |